carbidopa levodopa

Non-invasive, continuous oral delivery of solid levodopa-carbidopa for management of Parkinson’s disease

Nature.com - 05 Nov 2024
Non-invasive, continuous oral delivery of solid levodopa-carbidopa for management of Parkinson’s disease ...

Carbidopa/Levodopa Formulations & Parkinson's Disease | APDA

American Parkinson Disease Association - 08 Oct 2024
Carbidopa/Levodopa Formulations & Parkinson's Disease | APDA ...

FDA OKs Novel Levodopa-Based Continuous Sub-Q Regimen for Parkinson’s

Medscape - 18 Oct 2024
FDA OKs Novel Levodopa-Based Continuous Sub-Q Regimen for Parkinson’s ...

New Extended-Release Parkinson's Drug Approved

Medpage Today - 08 Aug 2024
New Extended-Release Parkinson's Drug Approved ...

FDA approves Vyalev for advanced Parkinson's disease

Medical Xpress - 23 Oct 2024
FDA approves Vyalev for advanced Parkinson's disease ...

3rd time's the charm: AbbVie scores FDA nod for continuous Parkinson's disease therapy Vyalev

FiercePharma - 17 Oct 2024
3rd time's the charm: AbbVie scores FDA nod for continuous Parkinson's disease therapy Vyalev ...

(Carbidopa and Levodopa) Extended-Release Capsules for

Business Wire - 23 Sep 2024
(Carbidopa and Levodopa) Extended-Release Capsules for ...

Safety and efficacy of continuous subcutaneous levodopa–carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial

The Lancet - 15 Mar 2024
Safety and efficacy of continuous subcutaneous levodopa–carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial ...

Avion Pharmaceutical's, LLC, Dhivy® (carbidopa/levodopa) and Parkinson's disease advocate, American Ninja Warrior, Jimmy Choi to participate at Rock Steady Boxing Coach Con Myrtle Beach

PR Newswire - 03 Oct 2024
Avion Pharmaceutical's, LLC, Dhivy® (carbidopa/levodopa) and Parkinson's disease advocate, American Ninja Warrior, Jimmy Choi to participate at Rock Steady Boxing Coach Con Myrtle Beach ...

FDA approves extended-release levodopa/carbidopa, now Crexont

Parkinson's News Today - 08 Aug 2024
FDA approves extended-release levodopa/carbidopa, now Crexont ...

$11.66 Billion Parkinson's Disease Market Forecast, 2030 by

GlobeNewswire - 07 Oct 2024
$11.66 Billion Parkinson's Disease Market Forecast, 2030 by ...

FDA Approves Lumyrz for Pediatric Narcolepsy, 24-Hour Foslevodopa/Foscarbidopa Gets FDA Greenlight, Oral Edaravone Fails in Phase 3 Study

Neurology Live - 19 Oct 2024
FDA Approves Lumyrz for Pediatric Narcolepsy, 24-Hour Foslevodopa/Foscarbidopa Gets FDA Greenlight, Oral Edaravone Fails in Phase 3 Study ...

Starting with 24-h levodopa carbidopa intestinal gel at initiation in a large cohort of advanced Parkinson’s disease patients

Nature.com - 14 Feb 2024
Starting with 24-h levodopa carbidopa intestinal gel at initiation in a large cohort of advanced Parkinson’s disease patients ...

(PDF) PEG‐J tube breakage in a patient with Parkinson's disease receiving levodopa‐carbidopa intestinal gel therapy

ResearchGate - 22 Oct 2024
(PDF) PEG‐J tube breakage in a patient with Parkinson's disease receiving levodopa‐carbidopa intestinal gel therapy ...

Home-Based Titration with Duodenal Infusion of Levodopa-Carbidopa Intestinal Gel in People with Parkinson’s Disease: An Observational Feasibility Study

Wiley Online Library - 08 Apr 2024
Home-Based Titration with Duodenal Infusion of Levodopa-Carbidopa Intestinal Gel in People with Parkinson’s Disease: An Observational Feasibility Study ...